AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Sep 8, 2005
35134_dirs_2005-09-08_a3db9912-3324-4ef8-a431-4e31bc1abb5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-08-31
Reporting Person: Nebeker Dilworth A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-08-28 | Croff Enterprises, Inc Class B Preferred Shares | U | 2900 | $3 | Disposed | 0 | Direct |
Footnotes
F1: These shares were sold pursuant to the Tender Offer for Class B Preferred Shares.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16